Press release
Huntington's Disease Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Prilenia Therapeutics, Neurocrine Biosciences, Som Biotech
The Huntington's Disease Market Forecast and Insights and the report offers an in-depth understanding of the Huntington's Disease, historical and forecasted epidemiology as well as the Huntington's Disease market trends in the 7MM.DelveInsight's "Huntington's Disease Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Huntington's Disease, historical and forecasted epidemiology as well as the Huntington's Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Huntington's Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Huntington's Disease Market Forecast [https://www.delveinsight.com/sample-request/huntingtons-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Huntington's Disease Market Report:
* The Huntington's Disease market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
* In April 2023, Prilenia Therapeutics disclosed the key findings from the Phase III PROOF-HD clinical trial in Huntington's Disease.
* In August 2023, The US FDA sanctioned the use of INGREZZA (valbenazine) capsules, a VMAT2 inhibitor, for managing chorea in adults with Huntington's disease.
* In February 2023, The US FDA authorized AUSTEDO XR, a novel once-daily tablet designed to address tardive dyskinesia and chorea associated with Huntington's disease in adults. AUSTEDO XR represents an extended-release formulation of the previously available AUSTEDO taken twice daily.
* In the 7MM population, there will be 81,000 cases of Huntington's disease overall in 2022. In the 7MM, the US had the highest number of frequently occurring cases of Huntington's disease, followed by Germany
* In Germany, there were correspondingly 300, 700, 1,200, and 2,000 cases of Huntington's disease among people aged 20 to 39, 40 to 49, 50 to 59, and 60 or older in 2022.
* In the 7MM, there were 39,000 treated instances of Huntington's disease overall in 2022; however, this number could rise during the projection period (2023-2022)
* Key Huntington's Disease Companies: Prilenia Therapeutics, Neurocrine Biosciences, Som Biotech, Annexon Biosciences, Vaccinex, Sage Therapeutics, UniQure Biopharma, Roche, Ionis Pharmaceuticals, Neurocrine Biosciences, Vaccinex, Azevan Pharmaceuticals, WaVe life Sciences, Luye Pharma Group, SOLA Biosciences, and others
* Key Huntington's Disease Therapies: Pridopidine(ACR-16; Huntexil), Ingrezza (valbenazine), SOM3355(bevantolol), ANX005, VX15/2503 (pepinemab), SAGE-718, AMT-130/ intrastriatal rAAV5-miHTT, RO7234292, Tominersen, Valbenazine, Pepinemab, SRX246, WVE-003, LPM3770164, SOL-175, and others
* The Huntington's Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Huntington's Disease pipeline products will significantly revolutionize the Huntington's Disease market dynamics.
Huntington's Disease Overview
Huntington's disease (HD) is a progressive and inherited neurological disorder that affects the brain's nerve cells, leading to gradual deterioration of cognitive, motor, and psychiatric functions. HD is caused by a mutation in the HTT gene, which produces a protein called huntingtin. The mutation leads to the production of an abnormal form of the huntingtin protein, which accumulates in neurons and disrupts their function.
Get a Free sample for the Huntington's Disease Market Report:
https://www.delveinsight.com/report-store/huntingtons-disease-market [https://www.delveinsight.com/report-store/huntingtons-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Huntington's Disease Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Huntington's Disease Epidemiology Segmentation:
The Huntington's Disease market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
* Total Prevalence of Huntington's Disease
* Prevalent Cases of Huntington's Disease by severity
* Gender-specific Prevalence of Huntington's Disease
* Diagnosed Cases of Episodic and Chronic Huntington's Disease
Download the report to understand which factors are driving Huntington's Disease epidemiology trends @ Huntington's Disease Epidemiology Forecast [https://www.delveinsight.com/sample-request/huntingtons-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Huntington's Disease Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Huntington's Disease market or expected to get launched during the study period. The analysis covers Huntington's Disease market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Huntington's Disease Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Huntington's Disease Therapies and Key Companies
* Pridopidine(ACR-16; Huntexil): Prilenia Therapeutics
* Ingrezza (valbenazine): Neurocrine Biosciences
* SOM3355(bevantolol): Som Biotech
* ANX005: Annexon Biosciences
* VX15/2503 (pepinemab): Vaccinex
* SAGE-718: Sage Therapeutics
* AMT-130/ intrastriatal rAAV5-miHTT: UniQure Biopharma
* RO7234292: Roche
* Tominersen: Ionis Pharmaceuticals
* Valbenazine: Neurocrine Biosciences
* Pepinemab: Vaccinex
* SRX246: Azevan Pharmaceuticals
* WVE-003: WaVe life Sciences
* LPM3770164: Luye Pharma Group
* SOL-175: SOLA Biosciences
Discover more about therapies set to grab major Huntington's Disease market share @ Huntington's Disease Treatment Market [https://www.delveinsight.com/sample-request/huntingtons-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Huntington's Disease Market Strengths
* As adult-onset Huntington's disease is more common than juvenile Huntington's disease, so with growing geriatricpopulation more elderly patients will be diagnosed with HD knowledge
Huntington's Disease Market Opportunities
* Huntington's disease is a rare condition thus, companies developing treatment options for the same can possess several advantages like premium pricing, an Orphan Designation, which comes along with 7 years of market exclusivity in the US, clinical trial subsidies, reduced regulatory fees, and several other benefits.
Scope of the Huntington's Disease Market Report
* Study Period: 2019-2032
* Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
* Key Huntington's Disease Companies: Prilenia Therapeutics, Neurocrine Biosciences, Som Biotech, Annexon Biosciences, Vaccinex, Sage Therapeutics, UniQure Biopharma, Roche, Ionis Pharmaceuticals, Neurocrine Biosciences, Vaccinex, Azevan Pharmaceuticals, WaVe life Sciences, Luye Pharma Group, SOLA Biosciences, and others
* Key Huntington's Disease Therapies: Pridopidine(ACR-16; Huntexil), Ingrezza (valbenazine), SOM3355(bevantolol), ANX005, VX15/2503 (pepinemab), SAGE-718, AMT-130/ intrastriatal rAAV5-miHTT, RO7234292, Tominersen, Valbenazine, Pepinemab, SRX246, WVE-003, LPM3770164, SOL-175, and others
* Huntington's Disease Therapeutic Assessment: Huntington's Disease current marketed and Huntington's Disease emerging therapies
* Huntington's Disease Market Dynamics: Huntington's Disease market drivers and Huntington's Disease market barriers
* Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
* Huntington's Disease Unmet Needs, KOL's views, Analyst's views, Huntington's Disease Market Access and Reimbursement
To know more about Huntington's Disease companies working in the treatment market, visit @ Huntington's Disease Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/huntingtons-disease-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Huntington's Disease Market Report Introduction
2. Executive Summary for Huntington's Disease
3. SWOT analysis of Huntington's Disease
4. Huntington's Disease Patient Share (%) Overview at a Glance
5. Huntington's Disease Market Overview at a Glance
6. Huntington's Disease Disease Background and Overview
7. Huntington's Disease Epidemiology and Patient Population
8. Country-Specific Patient Population of Huntington's Disease
9. Huntington's Disease Current Treatment and Medical Practices
10. Huntington's Disease Unmet Needs
11. Huntington's Disease Emerging Therapies
12. Huntington's Disease Market Outlook
13. Country-Wise Huntington's Disease Market Analysis (2019-2032)
14. Huntington's Disease Market Access and Reimbursement of Therapies
15. Huntington's Disease Market Drivers
16. Huntington's Disease Market Barriers
17. Huntington's Disease Appendix
18. Huntington's Disease Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=huntingtons-disease-market-is-expected-to-expand-at-a-healthy-growth-rate-during-the-forecast-period-20232032-states-delveinsight-prilenia-therapeutics-neurocrine-biosciences-som-biotech]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Huntington's Disease Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Prilenia Therapeutics, Neurocrine Biosciences, Som Biotech here
News-ID: 3464494 • Views: …
More Releases from ABNewswire
![The Hard Truth About Why Companies Are Failing To Meet Sustainable Packaging Goals](https://cdn.open-pr.com/X/9/X910245592_g.jpg)
The Hard Truth About Why Companies Are Failing To Meet Sustainable Packaging Goa …
As 2024 nears its close, major brand owners like PepsiCo (NYSE: PEP), Unilever (NYSE: UL), and Colgate-Palmolive (NYSE: CL) have admitted their failure to meet [https://packagingeurope.com/comment/what-lessons-can-be-learned-from-brands-missing-their-packaging-sustainability-targets/11676.article?utm_medium=email&utm_campaign=Packaging%20Connections%20-%20080824&utm_content=Packaging%20Connections%20-%20080824+CID_40bb0721c20c35dcda27368bb7144425&utm_source=News%20letters&utm_term=Read%20the%20full%20article] sustainable packaging objectives. While disappointing, this isn't a shock. Back in 2021, John Blake, senior director analyst at Gartner, had already forecasted these struggles [https://www.biztechreports.com/news-archive/2021/12/9/gartner-predicts-90-of-public-sustainable-packaging-commitments-wont-be-met-by-2025], citing the monumental challenges businesses would face in reaching such ambitious environmental goals. Now, companies are grappling not with…
![The Importance of Rapport and the Counselling Space in Kelowna: Accessing Support with Online Booking and Free Consultation](https://cdn.open-pr.com/X/9/X910571177_g.jpg)
The Importance of Rapport and the Counselling Space in Kelowna: Accessing Suppor …
In Kelowna, where the demand for counselling services [https://www.google.com/maps/place/Counselling+Services/@49.8867116,-119.4767924,15z/data=!4m6!3m5!1s0x537df4a77f8817d9:0xec00d65ec9a67b0b!8m2!3d49.8867116!4d-119.4767924!16s%2Fg%2F11d_2fwr1g?hl=en-GB&entry=ttu&g_ep=EgoyMDI0MDkwNC4wIKXMDSoASAFQAw%3D%3D] continues to grow, the importance of building a strong rapport between counsellor and client cannot be overstated. Whether individuals are seeking help with life transitions or managing ongoing challenges, the connection they establish with their counsellor is often the foundation of effective therapy. This bond, coupled with a supportive and welcoming counselling space, plays a critical role in the healing process.
One…
![Swagg Roofing & Siding Unveils State-of-the-Art Roof Repair Techniques in Billings](https://cdn.open-pr.com/X/9/X910362649_g.jpg)
Swagg Roofing & Siding Unveils State-of-the-Art Roof Repair Techniques in Billin …
Swagg Roofing & Siding unveiling of state-of-the-art roof repair techniques marks a significant advancement in the field of roofing. By integrating cutting-edge materials, diagnostic tools, and modern replacement options, the company is setting new benchmarks for quality and efficiency. The company's ongoing commitment to innovation and excellence ensures that it remains at the forefront of the roofing industry.
In the competitive landscape of roofing services, Swagg Roofing & Siding has recently…
![Hawa Who Unveils Debut Poetry Collection,](https://cdn.open-pr.com/X/9/X910149083_g.jpg)
Hawa Who Unveils Debut Poetry Collection, "Petals of My Heart": A Celebration of …
Pittsburgh, PA - September 9, 2024 - Hawa Who, a captivating new voice in contemporary poetry, announces the release of her highly anticipated debut collection, Petals of My Heart. This evocative exploration of love, loss, and self-discovery unfolds like a blooming flower, revealing the intricate layers of the human experience.
Image: https://www.abnewswire.com/uploads/bbe9fcb0adb51cca6f99bc6cfb116b89.png
Petals of My Heart invites readers on a deeply personal journey through universal themes. Divided into distinct chapters, the collection…
More Releases for Huntington
Huntingtin (Huntington Disease Protein or HTT)-Pipeline Review, H2 2017
"The Report Huntingtin (Huntington Disease Protein or HTT)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
According to the recently published report Huntingtin-Pipeline Review, H2 2017; Huntingtin (Huntington Disease Protein or HTT) pipeline Target constitutes close to 16 molecules. Out of which approximately 14 molecules are developed by companies and remaining by the universities/institutes.
Huntingtin (Huntington Disease Protein or HTT)-Huntingtin…
Huntington Disease Global Clinical Trials Review Market Research Report by Radia …
"Huntington Disease Global Clinical Trials Review, H2, 2017" provides an overview of Huntington Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Huntington Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and…
SCHOOL OF ROCK HUNTINGTON READY TO ROCK N’ ROLL
Huntington, NY (November 17, 2016) – School of Rock, the leader in performance-based music education, announces the opening of its newest school in Huntington, New York, located at 145 East Main Street, Huntington, New York 11743. Opening on November 19, the school will host a party from 11 a.m. to 4 p.m., featuring live music from School of Rock students. In addition to the opening party, School of Rock Huntington…
Huntington Beach Real Estate Agent Launches Luxury Home Buying Experience
The Malakai Sparks Group, a Huntington Beach, California-based realty agency spearheaded by president and real estate expert Malakai Sparks, announced the launch of its Huntington Beach Home Buying Experience service, which encompasses “curated experiences” from the entire Malakai Sparks Group team. Designed for the purpose of allowing prospective buyers to take in all Huntington Beach has to offer prior to purchasing a home – while making sure the area is…
Gershow Recycling of Huntington Hosts Customer Appreciation Day
On August 24, Gershow Recycling hosted its Customer Appreciation Day at its Huntington Station facility. Those in attendance received giveaways, enjoyed food, games and the chance to win raffle prizes provided by Gershow and WBAB Radio (102.3 FM), which also provided music for the event.
Gershow has eight locations in Brooklyn, New Hyde Park, Valley Stream, Freeport, Lindenhurst, Huntington Station, Bay Shore and Medford. For more information, call (631) 289-6188…
Huntington Beach 4th of July Parade Photographs
With the 2012 Huntington Beach Parade fast approaching, HuntingtonBeachParade.com is pleased to announce that it has published over 600 photos from the 2011 Huntington Beach 4th of July Parade.
The Huntington Beach 4th of July Parade photos include marching bands, military honor guards, various veterans organizations, colorful floats, vintage automobiles, local community organizations and businesses, multiple military flyovers, and much more.
The annual Huntington Beach 4th of July Parade is…